Novel PI3K inhibitor for Breast Cancer: Success at Last? Novel PI3K inhibitor for Breast Cancer: Success at Last?

A novel and highly selective PI3K inhibitor for breast cancer may succeed where two other similar but unselective drugs failed because of toxicity.Medscape Medical News

Source: Medscape Medical News Headlines - October 21, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news